Precision Wealth Strategies’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,924
Closed -$202K 90
2023
Q2
$202K Sell
2,924
-454
-13% -$32.3K 0.33% 60
2023
Q1
$251K Sell
3,378
-2,657
-44% -$223K 0.39% 53
2022
Q4
$562K Sell
6,035
-58
-1% -$5.6K 0.59% 29
2022
Q3
$578K Sell
6,093
-444
-7% -$43.9K 0.51% 37
2022
Q2
$611K Buy
6,537
+661
+11% +$64.5K 0.48% 39
2022
Q1
$595K Sell
5,876
-1,091
-16% -$115K 0.35% 54
2021
Q4
$719K Buy
6,967
+1,090
+19% +$101K 0.52% 49
2021
Q3
$499K Buy
5,877
+2,461
+72% +$206K 0.39% 57
2021
Q2
$285K Buy
3,416
+364
+12% +$29.8K 0.25% 80
2021
Q1
$230K Buy
+3,052
New +$222K 0.22% 75

Other funds holding CVS

Precision Wealth Strategies's CVS Position: Q3 2023 in Review

Precision Wealth Strategies sold out of CVS Health (CVS) in Q3 2023, closing a stake of 2,924 shares — an estimated $202K sold.

Precision Wealth Strategies first reported a position in CVS in Q1 2021 and held it in 10 quarters. The position peaked at $719K in Q4 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Precision Wealth Strategies reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Precision Wealth Strategies sold 2,924 CVS Health shares in Q3 2023, an estimated $202K.
  • Precision Wealth Strategies first reported a position in CVS Health in Q1 2021 and held it in 10 quarters.
  • Precision Wealth Strategies's CVS Health position peaked at $719K in Q4 2021.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Precision Wealth Strategies's 13F filing for Q3 2023, filed 31 Oct 2023.